NEXGEL (NASDAQ:NXGL) Releases Quarterly Earnings Results

NEXGEL (NASDAQ:NXGLGet Free Report) announced its quarterly earnings results on Monday. The company reported ($0.08) earnings per share (EPS) for the quarter, Zacks reports. NEXGEL had a negative return on equity of 71.19% and a negative net margin of 52.60%.

NEXGEL Price Performance

NASDAQ NXGL traded up $0.39 on Monday, hitting $3.09. The stock had a trading volume of 74,673 shares, compared to its average volume of 64,379. The firm has a 50-day moving average of $3.24 and a 200-day moving average of $3.27. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.93 and a current ratio of 1.51. NEXGEL has a 52-week low of $1.84 and a 52-week high of $5.10. The company has a market capitalization of $20.98 million, a price-to-earnings ratio of -5.33 and a beta of 0.62.

About NEXGEL

(Get Free Report)

NEXGEL, Inc manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc and changed its name to NEXGEL, Inc in November 2019.

Featured Articles

Earnings History for NEXGEL (NASDAQ:NXGL)

Receive News & Ratings for NEXGEL Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NEXGEL and related companies with MarketBeat.com's FREE daily email newsletter.